A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 109.82
GOOG 767.28
MSFT 60.12
BAC 21.85
FB 117.31

Recently Added

SF 49.66
FFIN 44.10
LAZ 42.60
III 3.90
TSO 89.21

Gaining Speed

SF 49.66
FFIN 44.10
III 3.90
LAZ 42.60
MCK 143.79

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!